Neurogene (NGNE) Tax Rate (2013 - 2014)
Neurogene's (NGNE) quarterly Tax Rate came in at 2.29% in Q4 2014, down 229.0% YoY from 1.77% in Q4 2013, and down 64907.8% on a QoQ basis from 0.0% in Q3 2014.
Neurogene (NGNE) Tax Rate (2013 - 2014) Analysis & Trends
Neurogene (NGNE) has 2 years of Tax Rate data on file, last reported at 2.29% in Q4 2014.
- Quarterly Tax Rate fell 229.0% year-over-year to 2.29% in Q4 2014, while the trailing twelve-month figure through Dec 2014 was 0.75% (changed N/A YoY) and the FY2015 annual result came in at 2.04%, down 127.0% from the prior year.
- Tax Rate retreated to 2.29% in Q4 2014, from 0.0% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.15% in Q3 2013 to a low of 2.29% in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Neurogene | 815.03 Mn | 815.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -2.29% |
| Dec 31, 2014 | -2.29% |
| Dec 31, 2014 | -2.29% |
| Sep 30, 2014 | 0.00% |
| Sep 30, 2014 | 0.00% |
| Sep 30, 2014 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.15% |
| Sep 30, 2013 | 0.15% |
| Sep 30, 2013 | 0.15% |